Does platelet mass influence the effectiveness of ibuprofen treatment for patent ductus arteriosus in preterm infants?

about

Association between Platelet Counts before and during Pharmacological Therapy for Patent Ductus Arteriosus and Treatment Failure in Preterm Infants.

P2860

Q52643460-E86D1973-E21A-42A0-A406-8C18FD990C0F

P2860

Does platelet mass influence the effectiveness of ibuprofen treatment for patent ductus arteriosus in preterm infants?

Item

http://www.wikidata.org/entity/Q40049385

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Does platelet mass influence t ...... arteriosus in preterm infants?

@en

type

Item

label

Does platelet mass influence t ...... arteriosus in preterm infants?

@en

prefLabel

Does platelet mass influence t ...... arteriosus in preterm infants?

@en

P1476

Does platelet mass influence t ...... arteriosus in preterm infants?

@en

P2093

Abdulhamit Tuten

http://www.w3.org/2001/XMLSchema#string

Elif Ozalkaya

http://www.w3.org/2001/XMLSchema#string

Emre Dincer

http://www.w3.org/2001/XMLSchema#string

Fahri Ovali

http://www.w3.org/2001/XMLSchema#string

Guner Karatekin

http://www.w3.org/2001/XMLSchema#string

Handan Hakyemez Toptan

http://www.w3.org/2001/XMLSchema#string

Hande Ozgun Karatepe

http://www.w3.org/2001/XMLSchema#string

Nilgun Karadag

http://www.w3.org/2001/XMLSchema#string

Selahattin Akar

http://www.w3.org/2001/XMLSchema#string

Sevilay Topcuoglu

http://www.w3.org/2001/XMLSchema#string

P2860

Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.

Platelets contribute to postnatal occlusion of the ductus arteriosus.

Low platelet count is associated with ductus arteriosus patency in preterm newborns.

Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus.

Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study.

Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment.

Patent ductus arteriosus of the preterm infant.

Diagnosis, Evaluation, and Management of Patent Ductus Arteriosus in Preterm Neonates.

Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

Predictors of successful closure of patent ductus arteriosus with indomethacin.

P304

3786-3789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14767058.2016.1145207

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26820601

http://www.w3.org/2001/XMLSchema#string

P921

preterm infant

Does platelet mass influence the effectiveness of ibuprofen treatment for patent ductus arteriosus in preterm infants?

about

P2860

P2860

Does platelet mass influence the effectiveness of ibuprofen treatment for patent ductus arteriosus in preterm infants?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921